These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 23335186

  • 1. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S, Ishikawa T.
    World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
    [Abstract] [Full Text] [Related]

  • 2. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ.
    Ann Clin Lab Sci; 2011 Dec; 41(4):360-3. PubMed ID: 22166506
    [Abstract] [Full Text] [Related]

  • 4. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L, Yaping L, Xiufen H.
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [Abstract] [Full Text] [Related]

  • 5. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 6. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
    [Abstract] [Full Text] [Related]

  • 7. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Sep 18; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 8. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M, Ayusawa M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2018 Apr 18; 60(4):342-348. PubMed ID: 29350882
    [Abstract] [Full Text] [Related]

  • 9. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
    Eur J Pediatr; 2016 Dec 18; 175(12):1997-2003. PubMed ID: 27798729
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D, Ayusawa M, Kato M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2016 Nov 18; 58(11):1105-1111. PubMed ID: 26991905
    [Abstract] [Full Text] [Related]

  • 11. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L, Dionne A, Meloche-Dumas L, Fournier A, Dahdah N.
    Pediatr Cardiol; 2020 Jun 18; 41(5):947-954. PubMed ID: 32172336
    [Abstract] [Full Text] [Related]

  • 12. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
    Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
    Pediatr Cardiol; 2009 Aug 18; 30(6):810-7. PubMed ID: 19365652
    [Abstract] [Full Text] [Related]

  • 13. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
    Rheumatol Int; 2016 Apr 18; 36(4):551-9. PubMed ID: 26849890
    [Abstract] [Full Text] [Related]

  • 14. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 18; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 15. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.
    Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M.
    Pediatr Int; 2000 Jun 18; 42(3):241-8. PubMed ID: 10881579
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
    Pediatr Int; 2017 Mar 18; 59(3):265-270. PubMed ID: 27589358
    [Abstract] [Full Text] [Related]

  • 17. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY, Han MY, Cha SH, Jeon YB.
    Pediatr Cardiol; 2013 Mar 18; 34(8):1837-43. PubMed ID: 23744100
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
    Int J Rheum Dis; 2022 Jan 18; 25(1):27-31. PubMed ID: 34750969
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-brain natriuretic peptide levels in patients with anomalous left coronary artery from pulmonary artery.
    Yunfei L, Qiang F, Yue W, Yongjun Q.
    J Cardiothorac Surg; 2020 Jan 13; 15(1):15. PubMed ID: 31931857
    [Abstract] [Full Text] [Related]

  • 20. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET.
    Perit Dial Int; 2006 Jan 13; 26(3):360-5. PubMed ID: 16722030
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.